Vidwan-ID : 520354



  • Dr Bhupinder Kumar

  • Assistant Professor
  • Hemvati Nandan Bahuguna Garhwal University
Publications 2016 - 2024

Publications

  • 29
    Journal Articles
  • 5
    Book Chapter
  • 37
    Review
  • 2
    Editorial
  • 1
    Book
  • 1
    Short Survey
  • 2
    Projects
  • 2
  • 3
  • 4
  • 64

Citations / H-Index

1647 Citations
23 h-index
1627 Citations

Altmetrics

27
25
52
756
1946

Google Scholar

Co-author Network


Expertise

Medicinal Chemistry

Drug Design and Development, Medicinal Chemistry, Computer Aided Drug Design

Personal Information

Dr Bhupinder Kumar

Male
Department of Pharmaceutical Science (Srinagar), Hemvati Nandan Bahuguna Garhwal University
Pauri Garhwal, Uttarakhand, - 246174


Experience

  • Assistant Professor

    Department of Pharmaceutical Science (Srinagar)

    Hemvati Nandan Bahuguna Garhwal University

  • Assistant Professor (Grade-III)

    ISF college of Pharmacy, Moga


Qualification

  • PhD

    Central University of Punjab


Honours and Awards

2018

CSIR-SRF

CSIR

2017

Indo-Austria Scientist Exchange fellowship

DST

2018

CSIR-SRF

CSIR

2017

Indo-Austria Scientist Exchange fellowship

DST

Read Less

Membership In Professional Bodies

2018

APTI

Life Member

2018

APTI

Life Member

Read Less

Membership In Committees

2024

Research and Development cell, HNBGU

Assistant Director

2023

Placement and Training Cell, HNBGU

Member

2023

Institutional Innovation Cell, HNBGU

Coordinator, IPR

2024

Research and Development cell, HNBGU

Assistant Director

2023

Placement and Training Cell, HNBGU

Member

2023

Institutional Innovation Cell, HNBGU

Coordinator, IPR

Read Less

Research Projects

Bioassay Guided Fractionation and Lead identification from Macrotyloma uniflorum (Gaheth): Exploring the Utility as Xanthine Oxidase Inhibitor for Treatment of Gout and Cancer

Funding Agency : UCOST, Dehradun

Synthesis and biological evaluation of new dihydroisoxazole based selective Cyclooxygenase-2 (COX-2) inhibitors with Hydrogen Sulphide (H2S) releasing assets for mitigating the pain and associated inflammation

Funding Agency : DBT

Bioassay Guided Fractionation and Lead identification from Macrotyloma uniflorum (Gaheth): Exploring the Utility as Xanthine Oxidase Inhibitor for Treatment of Gout and Cancer

Funding Agency : UCOST, Dehradun

Synthesis and biological evaluation of new dihydroisoxazole based selective Cyclooxygenase-2 (COX-2) inhibitors with Hydrogen Sulphide (H2S) releasing assets for mitigating the pain and associated inflammation

Funding Agency : DBT

Read Less

Patents




Read More






Read Less